Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.
Impact
If enacted, S08544 is expected to have significant implications for state laws governing the medical use of abortion-related drugs. By alleviating concerns about the criminalization of medical professionals who prescribe or dispense mifepristone under specified conditions, this bill seeks to support healthcare providers in ensuring that patients have access to necessary medical services without fear of legal repercussions. This could also mean easing restrictions previously imposed by law on pharmaceuticals that may have changed in status or labeling due to the evolving regulatory landscape.
Summary
Bill S08544 aims to amend both the penal law and education law concerning the prescribing and dispensing of mifepristone or any drug used for medication abortion. The bill specifically states that the prescribing, dispensing, or receipt of these drugs shall not be considered a criminal conversion act under certain circumstances, such as when the drugs no longer have federal approval or when they do not bear the current label. This legislative action is particularly relevant given the ongoing national debate regarding medication abortion and access to reproductive healthcare services.
Contention
Notably, the bill's implications may be contentious, as it directly intersects with broader societal and political debates surrounding abortion rights. Opponents may argue that this bill reflects an inappropriate leniency towards medication that they view as controversial, potentially leading to increased access to abortion services, which could go against their moral or political stances. Supporters, on the other hand, view it as a necessary measure to safeguard women's reproductive rights and health, ensuring that the law aligns with contemporary medical standards and practices.
Overall_context
Ultimately, S08544 exemplifies the shifting dynamics in state laws regarding healthcare, particularly in relation to reproductive rights. As states continue to grapple with changing federal guidelines and societal attitudes towards abortion, legislation like S08544 will play a critical role in shaping healthcare accessibility and the regulatory responsibilities of medical professionals.
Same As
Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.
Provides that the prescribing, dispensing, or receipt of mifepristone or any drug used for medication abortion shall not be considered a criminal conversion act under certain circumstances; provides that mifepristone or any drug used for medication abortion shall not be deemed to be adulterated or misbranded under certain circumstances.
Provides that the prescription label for medication abortion prescription drugs shall include the name of the dispensing health care practice instead of the name of the dispenser.
Provides that the prescription label for medication abortion prescription drugs shall include the name of the dispensing health care practice instead of the name of the dispenser.
Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.
Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.
Provides that mifepristone or misoprostol may be dispensed without the name and address of the dispenser and patient included on the prescription label.
Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.